These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 8625139)

  • 41. Can Carboplatin replace Cisplatin in small cell lung cancer?
    Noronha V
    Indian J Cancer; 2011; 48(4):452-3. PubMed ID: 22293259
    [No Abstract]   [Full Text] [Related]  

  • 42. The incidence and risk factors of febrile neutropenia in chemotherapy-naïve lung cancer patients receiving etoposide plus platinum.
    Fujiwara T; Kenmotsu H; Naito T; Kawamura T; Mamesaya N; Kotake M; Kobayashi H; Omori S; Nakashima K; Wakuda K; Ono A; Taira T; Murakami H; Omae K; Mori K; Endo M; Takahashi T
    Cancer Chemother Pharmacol; 2017 Jun; 79(6):1229-1237. PubMed ID: 28455585
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Intensive therapy for small-cell lung cancer using carboplatin alternating with cisplatin, ifosfamide, etoposide, mid-cycle vincristine, and radiotherapy.
    Prendiville J; Radford J; Thatcher N; Steward W; Ranson M; Burt P; Stout R
    J Clin Oncol; 1991 Aug; 9(8):1446-52. PubMed ID: 1649266
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Multiple cycles of PBPC-supported high-dose carboplatin and paclitaxel following mobilization with epirubicin and cisplatin are feasible but ineffective in treating patients with advanced non-small cell lung cancer.
    De Giorgi U; Rosti G; Ciucci G; Kopf B; Minzi C; Argnani M; Marangolo M
    Bone Marrow Transplant; 2007 Oct; 40(8):735-9. PubMed ID: 17700603
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Paclitaxel in combination chemotherapy with radiotherapy in patients with unresectable stage III non-small-cell lung cancer.
    Greco FA; Stroup SL; Gray JR; Hainsworth JD
    J Clin Oncol; 1996 May; 14(5):1642-8. PubMed ID: 8622083
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Concurrent 5-fluorouracil, leucovorin, etoposide, cisplatin and radiotherapy for locally advanced non-small cell lung cancer.
    Yang CT; Chang WC; Chen LH; Leung WM; Lee CH; Liaw CC
    Changgeng Yi Xue Za Zhi; 1997 Sep; 20(3):187-94. PubMed ID: 9397609
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Concurrent chemoradiotherapy for stage III non-small cell lung cancer].
    Hou HL; Hao JL; Pang QS; Wang P
    Zhonghua Yi Xue Za Zhi; 2010 Aug; 90(29):2068-70. PubMed ID: 21029648
    [TBL] [Abstract][Full Text] [Related]  

  • 48. One-hour paclitaxel in the treatment of non-small cell lung cancer.
    Hainsworth JD; Greco FA
    Semin Oncol; 1996 Dec; 23(6 Suppl 16):98-101. PubMed ID: 9007133
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A randomized trial of two platinum combinations in patients with advanced non-small cell lung cancer: a preliminary report. European Organization for the Research and Treatment of Cancer--Lung Cancer Working Party.
    Klastersky J; Sculier JP; Dabouis G; Bureau G; Libert P; Ravez P; Vandermoten G; Thiriaux J; Lecomte J; Cordier R
    Semin Oncol; 1990 Feb; 17(1 Suppl 2):20-4. PubMed ID: 2154855
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Combined chemotherapy and radiation therapy for non-small-cell lung cancer.
    Osoba D; Rusthoven JJ; Evans WK; Turnbull KA
    Semin Oncol; 1986 Sep; 13(3 Suppl 3):121-4. PubMed ID: 2429368
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cisplatin vs. carboplatin-based chemoradiotherapy in patients >65 years of age with stage III non-small cell lung cancer.
    Ezer N; Smith CB; Galsky MD; Mhango G; Gu F; Gomez J; Strauss GM; Wisnivesky J
    Radiother Oncol; 2014 Aug; 112(2):272-8. PubMed ID: 25150635
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Chemoradiation paradigm for the treatment of lung cancer.
    Eberhardt W; Pöttgen C; Stuschke M
    Nat Clin Pract Oncol; 2006 Apr; 3(4):188-99. PubMed ID: 16596143
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A randomized trial of postoperative adjuvant therapy in patients with completely resected stage II or IIIA non-small-cell lung cancer. Eastern Cooperative Oncology Group.
    Keller SM; Adak S; Wagner H; Herskovic A; Komaki R; Brooks BJ; Perry MC; Livingston RB; Johnson DH
    N Engl J Med; 2000 Oct; 343(17):1217-22. PubMed ID: 11071672
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Treatment of relapse of small cell lung cancer in selected patients with the initial combination chemotherapy carboplatin, etoposide, and epirubicin.
    Collard P; Weynants P; Francis C; Rodenstein DO
    Thorax; 1992 May; 47(5):369-71. PubMed ID: 1319088
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Role of radiotherapy of lung cancer].
    Mardynskiĭ IuS; Zolotkov AG; Kudriavtsev DV
    Vopr Onkol; 2006; 52(5):499-504. PubMed ID: 17168355
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Investigations of new drugs in combination with cisplatin in stage III non-small cell lung cancer.
    Vokes EE; Leopold KA; Herndon J; Green MR
    Semin Oncol; 1997 Jun; 24(3 Suppl 8):S8-42-S8-45. PubMed ID: 9207317
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [The results of combined treatment for stage III lung cancer including the use of intraoperative radiotherapy].
    Dobrodeev AIu; Zav'ialov AA; Tyzikov SA; Musabaeva LI
    Vopr Onkol; 2013; 59(5):606-10. PubMed ID: 24260889
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Concurrent paclitaxel, carboplatin, and radiation therapy for locally advanced non-small cell lung cancer.
    Choy H; Akerley W; DeVore RF
    Semin Oncol; 1999 Feb; 26(1 Suppl 2):36-43. PubMed ID: 10190782
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Concurrent radiotherapy and chemotherapy for non-small-cell lung cancer--continuous infusion of low dose cisplatin and 5-FU].
    Itoh Y; Fuwa N; Kikuchi Y; Matsumoto A; Muramoto H; Kato E; Shinoda M; Sugiura T
    Gan To Kagaku Ryoho; 1996 Oct; 23(12):1721-4. PubMed ID: 8886053
    [No Abstract]   [Full Text] [Related]  

  • 60. [Treatment of broncho-pulmonary cancer using carboplatin/etoposide: survival analysis].
    Skaventzos I; Weber T; Bury T; Radermecker MF
    Rev Med Liege; 1996 Nov; 51(11):718-20. PubMed ID: 9011926
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.